Plasma concentrations of caffeine and theophylline were simultaneously determined in 17 preterm infants after oral administration of aminophylline for treatment of apnoea. The ratio of caffeine/theophylline concentration in plasma increased during the first 2 weeks of treatment, owing to the longer time required for caffeine than for theophylline to reach steady state. The caffeine/theophylline ratio at steady state was 0.57±0.03 (mean±SE). Thus, caffeine contributed significantly to the total methylxanthine load in the infants. The plasma clearance of theophylline was calculated from the plasma steady state concentrations. In 3 preterm infants treated with oral aminophylline, repeated sampling showed an approximately linear increase in clearance with time from 16.8±0.4 (mean±SE) at a postnatal age of 6–11 days to 30.9±2.5 ml/kg/h at 64–69 days. In 1 full-term infant treated with oral theophylline from 3.5 to 11.5 months of age, the plasma clearance of theophylline increased in a roughly linear manner, reaching a plateau of about 100 ml/kg/h at 6–7 months of age. This corresponds to the clearance found in 1–4 year old infants.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Aldridge A, Aranda JV, Neims AH (1979) Caffeine metabolism in the newborn. Clin Pharmacol Ther 25: 447–453
Aranda JV, Sitar DS, Parsons W, Loughnan PM, Neims AH (1976) Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 295: 413–416
Aranda JV, Turmen T (1979) Methylxanthines in apnoea of prematurity. Clin Perinatol 6: 87–108
Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH (1979) Pharmacokinetic profile of caffeine in the premature newborn with apnoea. J Pediatr 94: 663–668
Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV (1978) Biotransformation of theophylline to caffeine in premature newborn. Lancet 2: 1204–1205
Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV (1979) Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr 94: 988–993
Brazier J-L, Renaud H, Ribou B, Salle BL (1979) Plasma xanthine levels in low birthweight infants treated or not treated with theophylline. Arch Dis Child 54: 194–199
Cottancin G, Baltassat P, Bory C, Challamel M-J, Frederich A (1977) Pharmacocinétique de la théophylline chez le noveauné de petit poids de naissance. Pédiatrie 32: 677–684
Floberg S, Lindström B, Lönnerholm G (1980) Simultaneous determination of theophylline and caffeine after extractive alkylation in small volumes of plasma by gas chromatography — mass spectrometry. J Chromatogr 221: 166–169
Giacoia G, Jusko WJ, Menke J. Koup JR (1976) Theophylline pharmacokinetics in premature infants with apnoea. J Pediatr 89: 829–832
Kuzemko JA, Paala J (1973) Apnoeic attacks in the newborn treated with aminophylline. Arch Dis Child 48: 404–406
Loughnan PM, Sitar DS, Ogilvie RI, Eisen A, Fox Z, Neims AH (1976) Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 88: 874–879
Ogilvie RI (1978) Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 3: 267–293
Peabody J, Neese AL, Lucey JG, Philip AGS, Soyka LF (1977) Decreased hypoxic, hyperoxic and bradycardic episodes as responses of neonates to theophylline. Pediatr Res 11: 419
Shannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, Moglan FMB (1975) Prevention of apnoea and bradycardia in low-birth-weight infants. Pediatrics 55: 589–594
Soyka LF, Neese AL (1978) Perinatal exposure to methylxanthines: Possible effects on pregnancy outcome. Clin Pharmacol Ther 23: 130
Takieddine FN, Tserng K-Y, King KC, Kalhan SC (1981) Postnatal development of theophylline metabolism in preterm infants. Semin Perionatol 5: 351–358
Turmen T, Davis J, Aranda JV (1981) Relationship of dose and plasma concentration of caffeine and ventilation in neonatal apnoea. Semin Perinatol 5: 326–331
Uauy R, Shapiro D, Smith B, Warshaw J (1975) Effect of theophylline on severe primary apnoea of prematurity. A preliminary report. Pediatrics 55: 595–598
About this article
Cite this article
Lönnerholm, G., Lindström, B., Paalzow, L. et al. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life. Eur J Clin Pharmacol 24, 371–374 (1983). https://doi.org/10.1007/BF00610057
- plasma level
- plasma clearance